Position in MRNA
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$226,266
-$56,359 QoQ
Shares Held
3,231
+35.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#488
of 777 holders
Holding Since
Jun 2024
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Premier Path Wealth Partners, LLC holds $2,006,754 across 6 Biotechnology names. MRNA ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,751 | $869,774 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
12,000 | $424,680 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
507 | $316,134 | |
| 4 | MRNA |
Moderna, Inc.
This page
|
3,231 | $226,266 | |
| 5 | ABUS |
Arbutus Biopharma Corp
|
30,000 | $144,000 | |
| 6 | AVXL |
Anavex Life Sciences Corp.
|
10,000 | $25,900 |
All Filings in MRNA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,266 | 3,231 | Shares | Sole | 2026-07-21 | |
| 2024-06-30 | $282,625 | 2,380 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||